Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

We have observed 6 EP applications Rachel Ann Jones has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after February 23, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13844762

PEPTIDES, DEVICES, AND METHODS FOR THE DETECTION OF EHRLICHIA ANTIBODIES

IPC classification:
G01N 33/53, G01N 33/554, G01N 33/567
Agent:
Rachel Ann Jones, Mewburn Ellis LLP
Agent:
Cooley (UK) LLP
Status:
EXAMINATION IN PROGRESS
EP15803007

SOLUBLE BACTERIAL AND FUNGAL PROTEINS AND METHODS AND USES THEREOF IN INHIBITING AND DISPERSING BIOFILM

IPC classification:
A01N 63/00, A01P 1/00, A01P 3/00, A61K 38/16, A61L 2/16, A61L 27/22, A61L 27/54, A61L 31/00, A61L 31/10, A61L 31/16, C12N 7/01, C12N 9/24, C12N 15/56, C12N 15/63, C12N 15/80
Applicant:
McGill University - Office of Sponsored Research
Applicant:
The Hospital For Sick Children
Agent:
Rachel Ann Jones, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15845094

RECOMBINANT FUSION PROTEIN FORMULATION

IPC classification:
A61K 39/395, A61K 47/02, A61K 47/10, A61K 47/18, A61K 47/22, A61K 47/26, A61P 27/02
Agent:
Rachel Ann Jones, Mewburn Ellis LLP
Status:
Request for examination was made
EP15844336

RECOMBINANT FUSION PROTEIN FORMULATION

IPC classification:
A61K 38/17, A61P 27/02, C07K 14/71, C07K 19/00
Agent:
Rachel Ann Jones, Mewburn Ellis LLP
Status:
Request for examination was made
EP15797300

IN VITRO PRODUCTION OF EXPANDED POTENTIAL STEM CELLS

IPC classification:
C12N 5/0735, C12N 5/074
Agent:
Rachel Ann Jones, Mewburn Ellis LLP
Status:
Request for examination was made
EP15804371

MENINGITIS B VACCINE

IPC classification:
A61K 39/095
Agent:
Rachel Ann Jones, Mewburn Ellis LLP
Status:
Request for examination was made

Please Sign in to use this feature